or Try an Advanced Search...

    ETF Components for MEDX - Horizon Kinetics Medical ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    LLY F -1.07 15.83
    ABBV F 2.01 7.81
    BMY B 0.44 6.23
    AMGN D 0.03 5.96
    NVS D 0.12 5.95
    AZN F 0.75 4.86
    JNJ D 1.06 4.65
    ALNY D 0.37 4.45
    PFE F -0.14 4.04
    MRK F 1.23 3.96
    ALKS C -0.38 3.91
    REGN F 0.41 3.38
    BIIB F 1.02 3.08
    CRSP D -2.56 2.97
    IONS F -1.62 2.78
    GSK F -0.43 2.32
    BCYC F -2.01 1.95
    BEAM D -1.33 1.51
    NTLA F 8.04 1.30
    REPL C -1.34 0.98
    GALT C -0.42 0.89
    HLN C 0.47 0.79
    VNDA C 0.00 0.79
    LTRN F -1.98 0.60
    EDIT F -1.04 0.53
    GEHC C -3.17 0.48
    TSVT F -0.64 0.41
    ALLO F 2.64 0.28
    VTRS A 0.65 0.27
    PACB D 2.03 0.13
    BLUE F -2.21 0.08
    MURA D -0.30 0.05

    Represented by ETF Holdings

    Keywords: Biotechnology S&P 500 Medicine Cancer Biopharmaceutical Depressive Disorder Pharmaceutical Products Cholesterol Infectious Diseases Life Sciences Diabetes Drugs Hypertension Inflammation Nasdaq 100 Neuroscience Ophthalmology Pain Schizophrenia Acid
    Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Diagnostics & Research Health Information Services

    Recent News for Horizon Kinetics Medical ETF & its Holdings

    Date Stock Title
    Nov 21 PFE Major companies that are also popular short-selling stocks
    Nov 21 PFE The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair
    Nov 21 VTRS Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)
    Nov 21 PFE Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
    Nov 21 PFE 2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
    Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
    Nov 21 GEHC GE HealthCare reiterates annual outlook, lifts dividend
    Nov 21 GEHC GE HealthCare Technologies raises dividend to $0.035/share
    Nov 21 AMGN Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
    Nov 21 GEHC GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
    Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
    Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
    Nov 21 AMGN Amgen picks prolific biotech founder Chang as new top scientist
    Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
    Nov 21 PFE EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia
    Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
    Nov 21 PFE 2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
    Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 AMGN Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
    The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.
    Exchange Traded Funds Index Fund Passive Management Warrant
    Back to the Main MEDX Page...